# A Non-Inferiority Trial of Stopping Penicillin in Early Rheumatic Heart Disease: GOAL-Stop

Study · id `cardio:ct-nct07146048` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07146048](<https://clinicaltrials.gov/study/NCT07146048>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07146048

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 922 participants.

## Technical summary

Registry record NCT07146048. Randomized; single masking; primary purpose treatment. Start 2026-03-23 (actual); primary completion 2029-02-20 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 922 participants (planned count; ClinicalTrials.gov record NCT07146048, source copy `cardio:ctgov-nct07146048-2026-06-22`, retrieved 2026-10-26)
- Started: 2026-03-23 (actual) (ClinicalTrials.gov record NCT07146048, source copy `cardio:ctgov-nct07146048-2026-06-22`, retrieved 2026-10-26)
- Primary completion: 2029-02-20 (anticipated) (ClinicalTrials.gov record NCT07146048, source copy `cardio:ctgov-nct07146048-2026-06-22`, retrieved 2026-10-26)
- Completion: 2029-12-31 (anticipated) (ClinicalTrials.gov record NCT07146048, source copy `cardio:ctgov-nct07146048-2026-06-22`, retrieved 2026-10-26)
- Countries: Uganda (ClinicalTrials.gov record NCT07146048, source copy `cardio:ctgov-nct07146048-2026-06-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07146048-2026-06-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Non-Inferiority Trial of Stopping Penicillin in Early Rheumatic Heart Disease: GOAL-Stop
- Acronym: GOAL-Stop
- Condition: Rheumatic Heart Disease
- Intervention (Drug): Secondary Prophylaxis
- Lead sponsor: Children's Hospital Medical Center, Cincinnati
- Lead sponsor class: OTHER
- Collaborator: Uganda Heart Institute
- Collaborator class: OTHER
- Collaborator: Coefficient Giving
- Collaborator class: OTHER
- Collaborator: Thrasher Research Fund
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Rheumatic heart disease (`cardio:rheumatic-heart-disease`)
- Registry lists this organization as the lead sponsor: Children's Hospital Medical Center, Cincinnati (`cardio:org-children-s-hospital-medical-center-cincinnati`)
- Registry lists this organization as a collaborator: Uganda Heart Institute (`cardio:org-uganda-heart-institute`)

## Provenance

Content hash: e25968df613a467f07ed4499cae1bcd5c6f3d685434929c7956d5a537ee3ed69
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
